rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1996-12-11
|
pubmed:abstractText |
Platelet function abnormalities contribute to the hemostatic defect in patients with cirrhosis. In this study we evaluated the occurrence of in vivo platelet activation as a possible mechanism of defective platelet aggregation in patients with cirrhosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0168-8278
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
436-43
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8738730-Aged,
pubmed-meshheading:8738730-Blood Coagulation Tests,
pubmed-meshheading:8738730-Female,
pubmed-meshheading:8738730-Flow Cytometry,
pubmed-meshheading:8738730-Humans,
pubmed-meshheading:8738730-Liver Cirrhosis,
pubmed-meshheading:8738730-Male,
pubmed-meshheading:8738730-Middle Aged,
pubmed-meshheading:8738730-Platelet Activation,
pubmed-meshheading:8738730-Platelet Aggregation,
pubmed-meshheading:8738730-Thromboxane B2
|
pubmed:year |
1996
|
pubmed:articleTitle |
Defective aggregation in cirrhosis is independent of in vivo platelet activation.
|
pubmed:affiliation |
Istituto di Medicina Interna, Università Degli Studi di Firenze, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|